Pembrolizumab held advanced head and neck cancers in a group of patients at bay for around two years.
source https://www.bbc.co.uk/news/health-50507069
Friday, November 22, 2019
Cancer immunotherapy drug 'less toxic and prolongs life'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment